irasia.com


Living Cell Technologies Limited

Corporate Information

Company Name Living Cell Technologies Limited
Registered Office Level 7, 330 Collins Street
Melbourne, VIC 3000, Australia

Phone: (61) 3 8689 9997
Fax: (61) 3 9602 4709

(Effective 1 January 2016)
Principal Place of Business New Zealand
PO Box 23 566
Hunters Corner
Manukau, Auckland 2155
New Zealand
Locations Corporate Office
Sydney, Australia

Operational Headquarters
Auckland, New Zealand
Sector Life Science / Bio-Technology / Pharmaceutical
GICS Industry Group Pharmaceuticals / Biotechnology & Life Sciences
Internet Homepage Address (URL) http://www.lctglobal.com
Phone Number (64) 9 276 2690
Fax Number (64) 9 276 2691
Email Address info@lctglobal.com
Follow LCT on Social Media Twitter - https://twitter.com/lctglobal
Financial Year End June 30
Board of Directors
  • Dr Bernard Tuch BSc, MBBS (Hons), FRACP, PhD and GAICD (Independent Director) [Appointed on 20 July 2011]; (Interim Chairman) [Appointed on 31 August 2018]

  • Dr Ken Taylor (Executive Director) [Effective from 31 August 2018]

  • Emeritus Professor Robert Elliott MBBS, MD, FRACP (Non-Executive Director)

  • Mr Laurie Hunter MA (Hons) (Independent Director)

  • Mr Robert Willcocks BA, LLM (Independent Director) [Appointed on 29 March 2011]


  • Mr Roy Austin BCom, CA (Chairman) [Appointed on 20 July 2011], (Independent Director) [Stepped down as chairman and director, effective from 31 August 2018]
  • Management Team
  • Dr Ken Taylor (Chief Executive) [Appointed on 8 July 2014]

  • Dr Kathleen Durbin (Head of Clinical and Regulatory)

  • Dr Janice Lam (Head of Operations)

  • Dr Sarah Carley (Quality Assurance Manager)

  • Mr Daya Uka (Head of Finance, IT and Corporate Services) [Appointed on 11 April 2018]
  • Joint Company Secretary Mr Mark Licciardo (Effective 1 January 2016)
    Ms Elizabeth McGregor (Effective 1 September 2018)
    Scientific Advisors
  • Professor Roger Barker, MD, PhD, FRCP

  • Professor Richard Faull, ONZM, MBChB, PhD, DSc, FRSNZ

  • Professor Anne B Young, MD, PhD

  • Dr Jackie Lee, PhD
  • (Scientific Advisor)
    Investor Relations Contact
  • Dr Ken Taylor (Chief Executive)

  • Principal Bankers Westpac Banking Corporation Limited
    Auditors BDO
    Level 11, 1 Margaret St
    Sydney, NSW 2000, Australia
    Phone: (61) 2 9251 4100
    Fax: (61) 2 9240 9821
    Website: www.bdo.com.au
    Lawyers Mr Gavin Robertson, Principal
    M+K Lawyers
    Level 21, 20 Bond Street
    Sydney, NSW 2000
    Australia
    Phone: (61) 2 8298 9534
    Fax: (61) 2 8298 9599

    Greenberg Traurig LLP
    Met Life Building
    200 Park Avenue
    New York, NY 10166
    USA

    Jones Young
    PO Box 189
    Shortland Street
    Auckland
    New Zealand

    AJ Park
    Level 14, AMP Centre
    29 Customs Street West
    Auckland 1010
    PO Box 565
    Auckland 1140
    New Zealand
    Share Registry Computershare Investor Services Pty Limited
    Level 4, 60 Carrington Street, Sydney, NSW 2000, Australia

    Postal Address: GPO Box 7045, Sydney, NSW 2001, Australia

    Phone: 1300 855 080 (within Australia)
                +61 3 9415 4000 (outside Australia)

    Email: www.investorcentre.com/contact

    Web: www.computershare.com

    (With effective from 8 July 2013)
    ASX Stock Code LCT
    Official Listing Date 1st September, 2004
    ADR LVCLY
    OTCQX LVCLY
    Date of Listing on OTCQX June 2008
    Year LCT was Formed 2003
    Market Capitalisation $63 M (as of 14 February 2017)

    $46 M (as of 25 August 2016)
    $39 M (as of 11 August 2016)

    $25 M (as of 25 March 2015)

    $30.2 M (as of 19 November 2013)

    A$18 M (as of 16 May 2012)

    A$45 M (as of 15 October 2010)
    Shares on issue 570,890,981 (as of 20 September 2017)
    Geographic shareholding split
    Australia - 51%
    New Zealand - 35%
    Japan - 4%
    Others - 10%

    (as of 13 February 2017)
    Substantial Holders
    ShareholdersNumber of shares
    Milford Asset Management36,078,640

    (as of 12 September 2017)
    Outstanding Shares 570,816,081 (as of 30 June 2017)
    Top 20 Shareholders 59% (as of 12 September 2017)
    Total number of shareholders 2,632 (as of 13 February 2017)
    Small parcel holders 407 holders of less than a marketable parcel of ordinary shares ( as of 31 August 2017)
    Outstanding Options 7,115,000 (as of 25 August 2016)
    Private Placement 74,117,647 shares at $0.085 to institutional and professional investors, raising $6.3m (as of 30 November 2016)
    Cash $6,861,663 (as of 30 June 2018)
    $7,472,018 (as of 31 March 2018)

    $5,247,820 (as of 31 December 2017)
    $6,042,810 (as of 30 September 2017)
    $7,530,033 (as of 30 June 2017)
    $8,126,890 (as of 31 March 2017)

    $8,623,788 (as of 31 December 2016)
    $4,436,282 (as of 30 September 2016)
    $5,301,999 (as of 30 June 2016)
    $5,208,798 (as of 31 March 2016)
    $5.9 M (as of 17 February 2016)

    $3,604,500 (as of 31 December 2015)
    $4,506,731 (as of 30 September 2015)
    $5,144,027 (as of 30 June 2015)
    $6,349,884 (as of 31 March 2015)

    $6,972,225 (as of 31 December 2014)
    $3,172,520 (as of 30 September 2014)
    $4,554,000 (as of 30 June 2014)
    $5,765,000 (as of 31 March 2014)

    $5,393,000 (as of 31 December 2013)
    $4,761,000 (as of 30 September 2013)
    A$4.504 M (as of 30 June 2013)
    $4.906 M (as of 31 March 2013)
    ABN 14 104 028 042

    updated 31st August, 2018


  • Company's Index
  • irasia.com

  • © Copyright 1996-2016 irasia.com Ltd. All rights reserved.
    DISCLAIMER: irasia.com Ltd makes no guarantee as to the accuracy or completeness of any information provided on this website. Under no circumstances shall irasia.com Ltd be liable for damages resulting from the use of the information provided on this website.
    TRADEMARK & COPYRIGHT: All intellectual property rights subsisting in the contents of this website belong to irasia.com Ltd or have been lawfully licensed to irasia.com Ltd for use on this website. All rights under applicable laws are hereby reserved. Reproduction of this website in whole or in part without the express written permission of irasia.com Ltd is strictly prohibited.
    TERMS OF USE: Please read the Terms of Use governing the use of our website.